JH

Jignasha Hardikbhai Nakum

Active Director Director DIN 11130014
DIN 11130014 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jignasha Hardikbhai Nakum

Data last updated:

Jignasha Hardikbhai Nakum is a Director at Vaxxus Pharmaceutical Private Limited (since 2025). The company operates in Pharma.

DIN 11130014
Primary Designation Director
Industry Pharma
First Appointment 31 May 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 May 20252024Active

Board colleagues of Jignasha Hardikbhai Nakum

Directorship timeline

Open interactive timeline →
Vaxxus Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jignasha Hardikbhai Nakum

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jignasha Hardikbhai Nakum

Jignasha Hardikbhai Nakum currently holds 1 directorship: Vaxxus Pharmaceutical Private Limited (Director, since 31 May 2025).

Jignasha Hardikbhai Nakum was first appointed on 31 May 2025 as Director at Vaxxus Pharmaceutical Private Limited.

The current boards of Jignasha Hardikbhai Nakum's companies include Abhijeet Mangal (Vaxxus Pharmaceutical Private Limited), Himanshi Bansal (Vaxxus Pharmaceutical Private Limited), Jyoti Agrawal (Vaxxus Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available